| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
258,990,000 |
| Market
Cap: |
19.45(B) |
| Last
Volume: |
1,576,803 |
Avg
Vol: |
1,916,356 |
| 52
Week Range: |
$65.11 - $87.67 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
| |
S&P SMALLCAP 600 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 317 |
| Guru Rank Value : 4 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Hologic develops, manufactures and supplies diagnostics products, medical imaging systems, and surgical products focused on women's health and well-being. Co.'s segments are: Diagnostics, which provides diagnostic products used in screening and diagnosis of human diseases; Breast Health, which provides solutions for breast cancer care in the areas of radiology, breast surgery, pathology and treatment; GYN Surgical, which include NovaSure endometrial ablation system, MyoSure hysteroscopic tissue removal system, Fluent fluid management system, as well as Acessa ProVu laparoscopic radiofrequency ablation system; and Skeletal Health, which include the Horizon DXA, a dual energy x-ray system.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
41,885 |
123,113 |
125,503 |
386,163 |
| Total Sell Value |
$3,164,051 |
$8,902,469 |
$9,102,584 |
$28,910,482 |
| Total People Sold |
4 |
6 |
6 |
11 |
| Total Sell Transactions |
4 |
8 |
9 |
19 |
| End Date |
2024-01-18 |
2023-10-17 |
2023-04-18 |
2022-04-18 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Garrett Scott T |
Director |
• • – |
2024-03-14 |
4 |
S |
$75.50 |
$1,241,296 |
D/D |
(16,441) |
48,611 |
|
0% |
|
| Garrett Scott T |
Director |
• • – |
2024-03-14 |
4 |
OE |
$26.74 |
$508,471 |
D/D |
16,441 |
65,052 |
|
- |
|
| Crawford Sally |
Director |
• • – |
2024-03-08 |
4 |
S |
$76.40 |
$690,607 |
D/D |
(9,039) |
132,927 |
|
3% |
|
| Crawford Sally |
Director |
• • – |
2024-03-08 |
4 |
OE |
$26.74 |
$241,703 |
D/D |
9,039 |
141,966 |
|
- |
|
| Dockendorff Charles J |
Director |
• • – |
2024-03-08 |
4 |
AS |
$76.21 |
$111,648 |
D/D |
(1,465) |
1,572 |
|
0% |
|
| Hantson Ludwig |
Director |
• • – |
2024-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,572 |
11,092 |
|
- |
|
| Crawford Sally |
Director |
• • – |
2024-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,572 |
132,927 |
|
- |
|
| Wendell Amy Mcbride |
Director |
• • – |
2024-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,572 |
20,730 |
|
- |
|
| Mohtashami Nanaz |
Director |
• • – |
2024-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,572 |
2,317 |
|
- |
|
| Garrett Scott T |
Director |
• • – |
2024-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,572 |
48,611 |
|
- |
|
| Stewart Stacey D. |
Director |
• • – |
2024-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,572 |
3,304 |
|
- |
|
| Dockendorff Charles J |
Director |
• • – |
2024-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,572 |
3,037 |
|
- |
|
| Stamoulis Christiana |
Director |
• • – |
2024-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,572 |
45,472 |
|
- |
|
| Oberton Karleen Marie |
Chief Financial Officer |
• • – |
2024-01-29 |
4 |
AS |
$75.00 |
$1,120,500 |
D/D |
(14,940) |
103,916 |
|
3% |
|
| Dockendorff Charles J |
Director |
• • – |
2024-01-02 |
4 |
AS |
$72.00 |
$1,153,224 |
D/D |
(16,017) |
1,465 |
|
7% |
|
| Dockendorff Charles J |
Director |
• • – |
2024-01-02 |
4 |
OE |
$38.44 |
$290,260 |
D/D |
7,551 |
17,482 |
|
- |
|
| Schnittker Brandon |
Div. President, GYN SurgicalOf |
• – – |
2024-01-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,278 |
|
4% |
|
| Dunne Peter Paul |
SVP, Human Resources |
• • – |
2023-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
1,231 |
10,643 |
|
- |
|
| Garrett Scott T |
Director |
• • – |
2023-12-11 |
4 |
S |
$68.71 |
$687,116 |
D/D |
(10,000) |
47,039 |
|
-9% |
|
| Dunne Peter Paul |
SVP, Human ResourcesOfficer |
• – – |
2023-12-07 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,412 |
|
9% |
|
| Macmillan Stephen P |
Chairman, President and CEO |
• • – |
2023-11-29 |
4 |
AS |
$70.41 |
$3,359,188 |
D/D |
(47,711) |
1,239,088 |
|
10% |
|
| Macmillan Stephen P |
Chairman, President and CEO |
• • – |
2023-11-29 |
4 |
OE |
$26.21 |
$1,250,505 |
D/D |
47,711 |
1,286,799 |
|
- |
|
| Mitchell Essex D |
Div. President, GYN Surgical |
• • – |
2023-11-21 |
4 |
S |
$71.85 |
$538,890 |
D/D |
(7,500) |
12,827 |
|
-8% |
|
| Schneiders Jennifer M |
President, Diag. Solutions |
• • – |
2023-11-14 |
4 |
A |
$0.00 |
$0 |
D/D |
3,475 |
6,337 |
|
- |
|
| Anderson Erik S |
Div. Pres., Breast & Skeletal |
• • – |
2023-11-14 |
4 |
A |
$0.00 |
$0 |
D/D |
3,822 |
16,490 |
|
- |
|
1694 Records found
|
|
Page 1 of 68 |
|
|
0.01 (0.01%) 
